(Q37996368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Investigation of NK cell function and their modulation in different malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Gordana Konjevic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Viktor Jovic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ana Vuletic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Katarina Mirjacic Martinovic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sandra Radenkovic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ivan Spuzic

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

139-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22442005%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12026-012-8285-7

26 January 2020

exact match

0 references

cites work

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

1 reference

12 December 2020

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

1 reference

12 December 2020

Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules

1 reference

12 December 2020

Modulation of the surface expression of CD158 killer cell Ig-like receptor by interleukin-2 and transforming growth factor-beta

1 reference

12 December 2020

Natural killer cell signaling pathways

1 reference

12 December 2020

Natural killer cells: from basic research to treatments

1 reference

12 December 2020

Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-gamma or interleukin-4.

1 reference

12 December 2020

Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.

1 reference

12 December 2020

Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.

1 reference

12 December 2020

KIR locus polymorphisms: genotyping and disease association analysis.

1 reference

12 December 2020

Interleukin 2 signaling involves the phosphorylation of Stat proteins

1 reference

12 December 2020

Activity of MMP-2 and MMP-9 in sera of breast cancer patients

1 reference

12 December 2020

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab

1 reference

12 December 2020

Effect of interleukin 2 on killer cell inhibitory receptors in patients with rheumatoid arthritis

1 reference

12 December 2020

NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction

1 reference

12 December 2020

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

12 December 2020

Activation of NK cell cytotoxicity

1 reference

12 December 2020

Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin's and non-Hodgkin's lymphomas

1 reference

12 December 2020

Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts

1 reference

12 December 2020

Modulation of tumor immunity by therapeutic monoclonal antibodies

1 reference

12 December 2020

Determination of lactate dehydrogenase isoenzymes in single lymphocytes from normal and leukemia cell lines

1 reference

12 December 2020

NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses

1 reference

12 December 2020

Modulation of 17beta-estradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors

1 reference

12 December 2020

TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma

1 reference

12 December 2020

[Steroid receptors and NK cell activity in patients with breast cancer]

1 reference

12 December 2020

Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors

1 reference

12 December 2020

Comparative studies of human FcRIII-positive and negative natural killer cells

1 reference

12 December 2020

Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha

1 reference

12 December 2020

Natural killer cell receptor signaling

1 reference

12 December 2020

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

1 reference

12 December 2020

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

12 December 2020

CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

1 reference

12 December 2020

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.

1 reference

12 December 2020

Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells

1 reference

12 December 2020

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo

1 reference

12 December 2020

Clinical stage-depending decrease of NK cell activity in multiple myeloma patients.

1 reference

12 December 2020

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

1 reference

12 December 2020

Natural killer cell developmental pathways: a question of balance.

1 reference

12 December 2020

[The possibilities of modulation of NK cell activity]

1 reference

12 December 2020

TNF-alpha induces changes in LDH isotype profile following triggering of apoptosis in PBL of non-Hodgkin's lymphomas.

1 reference

12 December 2020

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

1 reference

12 December 2020

Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells

1 reference

12 December 2020

Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors

1 reference

12 December 2020

[Mechanisms in onset of postoperative immunodepression and its importance in the surgical treatment of cancer patients]

1 reference

12 December 2020

Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action

1 reference

12 December 2020

In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients

1 reference

12 December 2020

Mini-review: defense strategies and immunity-related genes

1 reference

12 December 2020

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

12 December 2020

Estrogen receptors and breast cancer response to adrenalectomy

1 reference

12 December 2020

The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.

1 reference

12 December 2020

Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies

1 reference

12 December 2020

Regulation of the expression of lactate dehydrogenase isozymes in human lymphocytes

1 reference

12 December 2020

Regulation of the natural killer cell receptor repertoire

1 reference

12 December 2020

CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma

1 reference

12 December 2020

New views on natural killer cell-based immunotherapy for melanoma treatment.

1 reference

12 December 2020

Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells

1 reference

12 December 2020

[The effect of sera of breast cancer patients on NK cell activity]

1 reference

12 December 2020

Immunology and immunotherapy of human cancer: present concepts and clinical developments

1 reference

12 December 2020

Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency

1 reference

12 December 2020

Roles of the NKG2D immunoreceptor and its ligands

1 reference

12 December 2020

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

1 reference

12 December 2020

CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases

1 reference

12 December 2020

Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells

1 reference

12 December 2020

Estrogen dependence of primary breast cancer--correlation with histologic type and grade

1 reference

12 December 2020

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

1 reference

12 December 2020

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

1 reference

12 December 2020

Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells

1 reference

12 December 2020

Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells--an immunocytochemical study

1 reference

12 December 2020

Estrogen and progesterone receptor content in bilateral breast cancer

1 reference

12 December 2020

Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2.

1 reference

12 December 2020

Human natural killer cell development and biology

1 reference

12 December 2020

Cytokines in cancer pathogenesis and cancer therapy

1 reference

12 December 2020

Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation

1 reference

12 December 2020

Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients.

1 reference

12 December 2020

Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction

1 reference

12 December 2020

Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.

1 reference

12 December 2020

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

1 reference

12 December 2020

Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells

1 reference

12 December 2020

NKG2D ligands in tumor immunity

1 reference

12 December 2020

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

1 reference

12 December 2020

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

1 reference

12 December 2020

Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression

1 reference

12 December 2020

Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells

1 reference

12 December 2020

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

12 December 2020

Low natural killer cell activity in patients with malignant lymphoma

1 reference

12 December 2020

An aggressive extramedullary cutaneous plasmacytoma associated with extreme alterations in the innate immune system

1 reference

12 December 2020

The effect of serum on NK cell activity

1 reference

12 December 2020

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

12 December 2020

Human natural killer cell development

1 reference

12 December 2020

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells

1 reference

12 December 2020

[The significance of determination of NK cell activity in malignant diseases]

1 reference

12 December 2020

[Alterations in NK cell activity in the presence of sera of patients with metastases]

1 reference

12 December 2020

Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors

1 reference

12 December 2020

Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer

1 reference

12 December 2020

An enzyme-release assay for natural cytotoxicity

1 reference

12 December 2020

Biology of natural killer cells

1 reference

12 December 2020

The biology of human natural killer-cell subsets

1 reference

12 December 2020

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells

1 reference

12 December 2020

The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients

1 reference

12 December 2020

[NK cells in malignant diseases]

1 reference

12 December 2020

Distribution of several activating and inhibitory receptors on CD3-CD16+ NK cells and their correlation with NK cell function in healthy individuals.

1 reference

12 December 2020

Cancer genes: current status, future prospects, and applications in radiotherapy/oncology

1 reference

12 December 2020

Natural killer cells and dendritic cells: rendezvous in abused tissues

1 reference

12 December 2020

Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients

1 reference

12 December 2020

Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer

1 reference

12 December 2020

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

1 reference

12 December 2020

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

1 reference

12 December 2020

Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma

1 reference

12 December 2020

A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay

1 reference

12 December 2020

Immunomodulatory effect of serum on NK cells in vitro in healthy individuals

1 reference

12 December 2020

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor

1 reference

12 December 2020

Distinct requirements for IFNs and STAT1 in NK cell function

1 reference

12 December 2020

The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin's lymphoma patients.

1 reference

12 December 2020

1 reference

12 December 2020

[STAT proteins in cancerogenesis and therapy of malignancies]

1 reference

12 December 2020

Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes

1 reference

12 December 2020

Interplay of natural killer cells and their receptors with the adaptive immune response

1 reference

12 December 2020

TNF-alpha induced changes in cell membrane antigen expression on K-562 cells associated with increased lactate dehydrogenase (LDH) release.

1 reference

12 December 2020

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

1 reference

12 December 2020

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation

1 reference

12 December 2020